Construction of an SIV/HIV type 1 chimeric virus with the human interleukin 6 gene and its production of interleukin 6 in monkey and human cells

AIDS Research and Human Retroviruses

Volumn 16, Issue 6, 2000, Pages 577-582

  Haga, Takeshi ^a,b   Kuwata, Takeo ^a   Kozyrev, Ioury ^a   Kwofie, Theophilus B ^a   Hayami, Masanori ^a   Miura, Tomoyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHIMERA; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONKEY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

ANIMALS; CELL LINE; CELLS, CULTURED; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HAPLORHINI; HIV-1; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 0034630311     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200308990     Document Type: Article

References (23)

1. Clerici M and Shearer GM: A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14(3): 107-111.
2. Breen EC, Rezai AR, Nakajima K, et al.: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144(2):480-484.
3. Schnittman SM, Singer KH, Greenhouse JJ, et al.: Thymic microenvironment induces HIV expression. Physiologic secretion of IL-6 by thymic epithelial cells up-regulates virus expression in chronically infected cells. J Immunol 1991;147(8):2553-2558.
4. Rieckmann P, Poli G, Kehrl JH, and Fauci AS: Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1. J Exp Med 1991;173(1):1-5.
5. Poli G, Bressler P, Kinter A, et al.: Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and posttranscriptional mechanisms. J Exp Med 1990;172(1):151-158.
6. Marfaing-Koka A, Aubin JT, Grangeot-Keros L, et al.: In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients. J Acquir Immune Defic Syndr Hum Retroviral 1996;11(1):59-68.
7. Benveniste O, Vaslin B, Le Grand R, and Dormont D: Comparing IL-6, TNF-alpha, and IL-1 beta responses to acute infection with attenuated nef-truncated or pathogenic SIVmac251 in macaque peripheral blood mononuclear cells. J Acquir Immune Defic Syndr Hum Retroviral 1998;18(4):389-390. [Letter]
8. Haga T, Kuwata T, Ui M, Igarashi T, Miyazaki Y, and Hayami M: A new approach to AIDS research and prevention: The use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines. Microbiol Immunol 1998;42(4):245-251.
9. Kuwata T, Igarashi T, Ido E, et al.: Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef or different parental origins and their in vitro and in vivo replication. J Gen Virol 1995;76(Pt 9):2181-2191.
10. Kozak M: Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. Microbiol Rev 1983;47(1): 1-45.
11. Clapham PR, Weiss RA, Dalgleish AG, Exley M, Whitby D, and Hogg N: Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: Receptor modulation and differentiation induced by phorbol ester. Virology 1987;158(1):44-51.
12. Naidu YM, Kestler HWd, Li Y, et al.: Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: Persistent infection of rhesus monkeys with molecularly cloned SIVmac. J Virol 1988;62(12):4691-4696.
13. Igarashi T, Shibata R, Hasebe F, et al.: Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys. AIDS Res Hum Retroviruses 1994; 10(8):1021-1029.
14. Ida N, Sakurai S, Hosaka T, et al.: An enzyme-linked immunosorbent assay for the measurement of human interleukin-6. J Immunol Methods 1990;133(2):279-284.
15. Muraguchi A, Hirano T, Tang B, et al.: The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988;167(2):332-344.
16. Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, and Ueno K: A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 1997;44:1299-1305.
17. Sopper S, Demuth M, Stahl-Hennig C, et al.: The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology 1996;220:320-329.
18. Gundlach BR, Linhart DH, Dittmer U, et al.: Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. J Virol 1997;71(3):2225-2232.
19. Giavedoni LD and Yilma T: Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J Virol 1996;70(4):2247-2251.
20. Giavedoni L, Ahmad S, Jones L, and Yilma T: Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J Virol 1997;71(2):866-872.
21. Quinto I, Mallardo M, Baldassarre F, Scala G, Englund G, and Jeang KT: Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development. J Biol Chem 1999;274(25):175 67-17572.
22. Lindley T, Virk KP, Ronchetti-Blume M, et al.: Construction and characterization of adenovirus co-expressing hepatitis B virus surface antigen and interleukin-6. Gene 1994;138(1-2):165-170.
23. Hayami M, Igarashi T, Kuwata T, et al.: Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use. Leukemia 1999;13(Suppl. 1):S42-S47.